IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the impact of pharmacological myocardial metabolic
support, in the form of intravenous (IV) glucose, insulin and potassium (GIK), for the
treatment of patients with threatened or established acute myocardial infarction (AMI).